Tags

Type your tag names separated by a space and hit enter

Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets.
Arch Pharm Res. 2010 Mar; 33(3):395-403.AP

Abstract

A work has been done to study the individual and interacting effects of formulation variables, using a 23 fractional factorial design. The effects of five variables, namely, relative density of tablets, nature and concentration of binder, compression process, and compression speed on the tensile strength and percent survival of Bacillus subtilis spores in diclofenac tablet formulations were determined. The effects of these variables were studied both singly and when they interact with each other in two fractional designs (Woolfall, 1964). The first fraction comprised of nature (N) and concentration (C) of binder, and relative density of tablets (D) while in the second fraction, compression speed (S), compression process (P) and relative density of tablets (D) were studied. In the first fraction, concentration of binder had the highest effect on tensile strength with the ranking C > D > N for both DCS (formulation containing Corn starch) and DDCP (formulation containing DCP), and C > N > D for DL (formulation containing Lactose). On the percent survival of Bacillus subtilis, relative density of tablets showed the highest effect with the ranking D > C > N for both DCS and DL, and D > N > C for DDCP. In the second fraction, compression speed generally had a great effect on both tensile strength and percent survival in all the formulations. The results of interactions among the variables showed the highest effect on tensile strength from interaction between concentration of binder and relative density of tablets (C-D) while interaction between compression speed and relative density of tablets (S-D) had the highest effect on percent survival in all the formulations. A fractional factorial design proved suitable in determining the magnitude of both the individual and interacting effects of the variables. The study showed that each of these variables has to be properly considered in producing tablets of satisfactory strength and reduced microbial survival.

Authors+Show Affiliations

Department of Pharmaceutics and Pharmaceutical Technology, Olabisi Onabanjo University, Sagamu, Ogun, 20022, Nigeria. shogo205@yahoo.comNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20361304

Citation

Ayorinde, John O., and Oludele A. Itiola. "Individual and Interacting Effects of Formulation Variables On the Tensile Strength and Microbial Survival in Diclofenac Tablets." Archives of Pharmacal Research, vol. 33, no. 3, 2010, pp. 395-403.
Ayorinde JO, Itiola OA. Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets. Arch Pharm Res. 2010;33(3):395-403.
Ayorinde, J. O., & Itiola, O. A. (2010). Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets. Archives of Pharmacal Research, 33(3), 395-403. https://doi.org/10.1007/s12272-010-0308-0
Ayorinde JO, Itiola OA. Individual and Interacting Effects of Formulation Variables On the Tensile Strength and Microbial Survival in Diclofenac Tablets. Arch Pharm Res. 2010;33(3):395-403. PubMed PMID: 20361304.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets. AU - Ayorinde,John O, AU - Itiola,Oludele A, Y1 - 2010/03/30/ PY - 2009/06/01/received PY - 2009/12/04/accepted PY - 2009/10/20/revised PY - 2010/4/3/entrez PY - 2010/4/3/pubmed PY - 2010/6/18/medline SP - 395 EP - 403 JF - Archives of pharmacal research JO - Arch Pharm Res VL - 33 IS - 3 N2 - A work has been done to study the individual and interacting effects of formulation variables, using a 23 fractional factorial design. The effects of five variables, namely, relative density of tablets, nature and concentration of binder, compression process, and compression speed on the tensile strength and percent survival of Bacillus subtilis spores in diclofenac tablet formulations were determined. The effects of these variables were studied both singly and when they interact with each other in two fractional designs (Woolfall, 1964). The first fraction comprised of nature (N) and concentration (C) of binder, and relative density of tablets (D) while in the second fraction, compression speed (S), compression process (P) and relative density of tablets (D) were studied. In the first fraction, concentration of binder had the highest effect on tensile strength with the ranking C > D > N for both DCS (formulation containing Corn starch) and DDCP (formulation containing DCP), and C > N > D for DL (formulation containing Lactose). On the percent survival of Bacillus subtilis, relative density of tablets showed the highest effect with the ranking D > C > N for both DCS and DL, and D > N > C for DDCP. In the second fraction, compression speed generally had a great effect on both tensile strength and percent survival in all the formulations. The results of interactions among the variables showed the highest effect on tensile strength from interaction between concentration of binder and relative density of tablets (C-D) while interaction between compression speed and relative density of tablets (S-D) had the highest effect on percent survival in all the formulations. A fractional factorial design proved suitable in determining the magnitude of both the individual and interacting effects of the variables. The study showed that each of these variables has to be properly considered in producing tablets of satisfactory strength and reduced microbial survival. SN - 0253-6269 UR - https://www.unboundmedicine.com/medline/citation/20361304/Individual_and_interacting_effects_of_formulation_variables_on_the_tensile_strength_and_microbial_survival_in_diclofenac_tablets_ L2 - https://dx.doi.org/10.1007/s12272-010-0308-0 DB - PRIME DP - Unbound Medicine ER -